A metagenomics-based diagnostic approach for central nervous system infections in hospital acute care setting. Academic Article uri icon

Overview

abstract

  • The etiology of central nervous system (CNS) infections such as meningitis and encephalitis remains unknown in a large proportion of cases partly because the diversity of pathogens that may cause CNS infections greatly outnumber available test methods. We developed a metagenomic next generation sequencing (mNGS)-based approach for broad-range detection of pathogens associated with CNS infections suitable for application in the acute care hospital setting. The analytical sensitivity of mNGS performed on an Illumina MiSeq was assessed using simulated cerebrospinal fluid (CSF) specimens (n = 9). mNGS data were then used as a training dataset to optimize a bioinformatics workflow based on the IDseq pipeline. For clinical validation, residual CSF specimens (n = 74) from patients with suspected CNS infections previously tested by culture and/or PCR, were analyzed by mNGS. In simulated specimens, the NGS reads aligned to pathogen genomes in IDseq were correlated to qPCR CT values for the respective pathogens (R = 0.96; p < 0.0001), and the results were highly specific for the spiked pathogens. In clinical samples, the diagnostic accuracy, sensitivity and specificity of the mNGS with reference to conventional methods were 100%, 95% and 96%, respectively. The clinical application of mNGS holds promise to benefit patients with CNS infections of unknown etiology.

publication date

  • July 8, 2020

Research

keywords

  • Central Nervous System Infections
  • Cerebrospinal Fluid
  • Metagenome
  • Metagenomics

Identity

PubMed Central ID

  • PMC7343800

Scopus Document Identifier

  • 85087710907

Digital Object Identifier (DOI)

  • 10.1007/s00284-018-01624-1

PubMed ID

  • 32641704

Additional Document Info

volume

  • 10

issue

  • 1